Chronic Obstructive Pulmonary Disease (COPD) Market Sees Accelerated Growth Amid Rising Global Burden
The global Chronic Obstructive Pulmonary Disease (COPD) market is undergoing a transformative phase as healthcare systems worldwide shift their focus toward improving long-term respiratory care. With an alarming rise in COPD prevalence, especially in aging populations and among smokers, the demand for early diagnosis, effective treatment, and integrated care models has never been higher.
Global COPD Burden Prompting Strategic Healthcare Response
COPD is a progressive, life-threatening lung disease that causes breathing difficulties due to long-term exposure to harmful particles or gases. It includes conditions such as emphysema and chronic bronchitis. Despite being preventable and treatable, COPD remains one of the leading causes of morbidity and mortality globally.
Increasing industrialization, urban air pollution, and tobacco use—both active and passive—have significantly contributed to the global disease burden. In low- and middle-income countries, the situation is further aggravated by limited access…
